Lv5
1580 积分 2021-08-17 加入
PRT3789 is a First-in-Human SMARCA2-Selective Degrader that Induces Synthetic Lethality in SMARCA4-Mutated Cancers
2天前
已完结
Synthetic lethal strategies for the development of cancer therapeutics
1个月前
已完结
Cancer immunology data engine reveals secreted AOAH as a potential immunotherapy
1个月前
已完结
Discovery and preclinical evaluations of TQB3616, a novel CDK4-biased inhibitor
1个月前
已完结
Disparities in 36 cancers across 185 countries: secondary analysis of global cancer statistics
1个月前
已完结
Discovery of YK-029A, a novel mutant EGFR inhibitor targeting both T790 M and exon 20 insertion mutations, as a treatment for NSCLC
2个月前
已完结
Abstract 5921: PH027-1, a potent and selective small-molecule WRN inhibitor that targets MSI-H tumors
2个月前
已关闭
Turnover atlas of proteome and phosphoproteome across mouse tissues and brain regions
2个月前
已完结
PAQR4 has a tumorigenic effect in human breast cancers in association with reduced CDK4 degradation
3个月前
已完结
Development of PROTAC degrader probe of CDK4/6 based on DCAF16
3个月前
已完结
皖公网安备34019202002308
